CIAPIN1 as a Promoter of Oral Squamous Cell Carcinoma Progression
Journal of Oral Pathology & Medicine · 2026
DOI: 10.1111/jop.70083 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Oral Pathology & Medicine, 2026. Verfasst von Shan Yang und 8 weiteren Autor:innen. Beteiligte Einrichtung: The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, People's Republic of China. Hauptthemen laut MEDLINE: Mouth Neoplasms, Carcinoma, Squamous Cell, Intracellular Signaling Peptides and Proteins. Die Arbeit nennt 23 Literaturangaben. Gefördert von: Natural Science Foundation of Heilongjiang Province, First Affiliated Hospital of Harbin Medical University Overseas Study Fund, Outstanding youth fund of the First Affiliated Hospital of Harbin Medical University.
Abstract (Originalsprache)
Objective
This study aims to investigate the relationship between the expression of cytokine‐induced apoptosis inhibitor 1 (CIAPIN1) and the development of oral squamous cell carcinoma (OSCC). Materials and Methods Bioinformatics analyzed CIAPIN1 in pan‐cancers; IHC detected CIAPIN1 expression in OSCC and healthy samples; qRT‐PCR and WB assayed CIAPIN1 mRNA and protein levels in OSCC and normal cells; MTT, scratch, transwell, flow cytometry, and WB evaluated OSCC cell viability, migration, invasion, EMT, and apoptosis after CIAPIN1 knockdown.
Results
CIAPIN1 abnormally expressed in multiple tumors, especially OSCC, is linked to prognosis. IHC showed elevated CIAPIN1 in OSCC tissues ( p < 0.001). qRT‐PCR and WB results showed CIAPIN1 was upregulated in CAL‐27 (qRT‐PCR: p < 0.05, WB: p < 0.05), SAS (qRT‐PCR: p < 0.05, WB: p < 0.01), and SCC9 (qRT‐PCR: p < 0.01, WB: p < 0.001) cells compared to HOK cells. After the knockdown of CIAPIN1 in SAS and SCC9 cells, MTT assays revealed reduced cell viability (SAS: p < 0.001, SCC9: p < 0.001); scratch tests showed suppressed migration ability (SAS: p < 0.01, SCC9: p < 0.001); transwell assays indicated inhibited invasion capability (SAS: p < 0.01, SCC9: p < 0.001); flow cytometry revealed increased apoptosis rates (SAS: p < 0.01, SCC9: p < 0.01); WB analysis showed reduced N‐cadherin expression and increased E‐cadherin expression (SAS for N‐cadherin: p < 0.05, SCC9 for N‐cadherin: p < 0.01; SAS for E‐cadherin: p < 0.01, SCC9 for E‐cadherin: p < 0.05), indicating CIAPIN1 promotes EMT.
Conclusion
CIAPIN1 contributes to the malignant progression of oral squamous cell carcinoma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, People's Republic of China.
ORCID-Profile: Changsheng Sun
Förderung
- Natural Science Foundation of Heilongjiang Province
- First Affiliated Hospital of Harbin Medical University Overseas Study Fund
- Outstanding youth fund of the First Affiliated Hospital of Harbin Medical University
Zitieren
APA
Yang, S., Sun, C., Fang, Z., Jin, H., Li, C., Zang, H., Yang, L., Li, L., & Saiyin, W. (2026). CIAPIN1 as a Promoter of Oral Squamous Cell Carcinoma Progression. Journal of Oral Pathology & Medicine. https://doi.org/10.1111/jop.70083
Vancouver
Yang S, Sun C, Fang Z, Jin H, Li C, Zang H, et al. CIAPIN1 as a Promoter of Oral Squamous Cell Carcinoma Progression. Journal of Oral Pathology & Medicine. 2026. doi:10.1111/jop.70083
BibTeX
@article{Yang2026,
author = {Yang, Shan and Sun, Changsheng and Fang, Zhikai and Jin, Hui and Li, Chang and Zang, Hongfeng and Yang, Liu and Li, Lili and Saiyin, Wuliji},
title = {CIAPIN1 as a Promoter of Oral Squamous Cell Carcinoma Progression},
journal = {Journal of Oral Pathology & Medicine},
year = {2026},
doi = {10.1111/jop.70083}
}
EUVIMED